(OHI) Omega Healthcare Investors - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6819361006
OHI EPS (Earnings per Share)
OHI Revenue
OHI: Financing, Capital, Investments, Facilities, Nursing, Capital
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust (REIT) that specializes in providing financing and capital to the long-term healthcare industry, focusing on skilled nursing facilities in the US and UK. With a vast portfolio of 1,000 operating facilities across 42 states and the UK, Omega works with 86 different operators, continually assessing industry trends and challenges to identify high-quality, long-term investments that balance risk and reward for its investors.
As a leading healthcare REIT, Omegas business model is designed to capitalize on the growing demand for long-term care services, driven by an aging population and an increasing need for healthcare infrastructure. The companys diversified portfolio and extensive network of operators position it for long-term success, with a focus on partnering with high-quality operators to deliver stable returns to investors.
Analyzing the current market data, OHIs stock price is at $37.60, with a 20-day SMA of $36.65, indicating a positive trend. The stock is trading above its 50-day and 200-day SMAs, suggesting a stable upward momentum. With an ATR of 0.73, representing a 1.94% daily volatility, the stock is experiencing moderate fluctuations. Given the current P/E ratio of 22.48 and a forward P/E of 10.13, the stock appears to be reasonably valued, with potential for long-term growth.
Based on the available data, a forecast for OHIs stock price could be constructed by analyzing the interplay between its technical and fundamental indicators. With a market capitalization of $10.773 billion and a RoE of 10.42%, the company demonstrates a stable financial position. Considering the 52-week high and low prices of $40.36 and $29.37, respectively, and the current price of $37.60, it is likely that the stock will continue to experience moderate growth, potentially reaching $42.00 in the next 6-12 months, driven by its strong industry position and favorable market trends.
Additional Sources for OHI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
OHI Stock Overview
Market Cap in USD | 11,017m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1992-08-07 |
OHI Stock Ratings
Growth Rating | 55.2 |
Fundamental | 34.1 |
Dividend Rating | 63.6 |
Rel. Strength | 7.48 |
Analysts | 3.69 of 5 |
Fair Price Momentum | 39.67 USD |
Fair Price DCF | 57.82 USD |
OHI Dividends
Dividend Yield 12m | 7.26% |
Yield on Cost 5y | 13.45% |
Annual Growth 5y | 0.00% |
Payout Consistency | 85.8% |
Payout Ratio | 1.6% |
OHI Growth Ratios
Growth Correlation 3m | -18.2% |
Growth Correlation 12m | 11.5% |
Growth Correlation 5y | 78.3% |
CAGR 5y | 13.14% |
CAGR/Max DD 5y | 0.46 |
Sharpe Ratio 12m | 0.88 |
Alpha | 16.26 |
Beta | 0.128 |
Volatility | 24.03% |
Current Volume | 6195.5k |
Average Volume 20d | 2394.6k |
As of June 21, 2025, the stock is trading at USD 36.95 with a total of 6,195,518 shares traded.
Over the past week, the price has changed by -0.19%, over one month by -1.52%, over three months by +0.06% and over the past year by +21.21%.
Neither. Based on ValueRay´s Fundamental Analyses, Omega Healthcare Investors is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.08 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OHI is around 39.67 USD . This means that OHI is currently overvalued and has a potential downside of 7.36%.
Omega Healthcare Investors has received a consensus analysts rating of 3.69. Therefor, it is recommend to hold OHI.
- Strong Buy: 4
- Buy: 3
- Hold: 9
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, OHI Omega Healthcare Investors will be worth about 42.8 in June 2026. The stock is currently trading at 36.95. This means that the stock has a potential upside of +15.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 40.4 | 9.2% |
Analysts Target Price | 40.4 | 9.4% |
ValueRay Target Price | 42.8 | 15.9% |